Literature DB >> 32588060

Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial.

Jun-Jie Zhang1, Fei Ye1, Kai Xu2, Jing Kan1, Ling Tao3, Teguh Santoso4, Muhammad Munawar5, Damras Tresukosol6, Li Li7, Imad Sheiban8, Feng Li9, Nai-Liang Tian10, Alfredo E Rodríguez11, Chotnoparatpat Paiboon12, Francesco Lavarra13, Shu Lu14, Kitigon Vichairuangthum15, Hesong Zeng16, Lianglong Chen17, Ruiyan Zhang18, Shiqin Ding19, Fengtang Gao20, Zening Jin21, Lang Hong22, Likun Ma23, Shangyu Wen24, Xueming Wu25, Song Yang26, Wei-Hsian Yin27, Jun Zhang28, Yan Wang29, Yonghong Zheng30, Lei Zhou31, Limin Zhou32, Yuansheng Zhu33, Tan Xu34, Xin Wang35, Hong Qu36, Yulong Tian37, Song Lin38, Lijun Liu39, Qinghua Lu40, Qihua Li41, Bo Li42, Qing Jiang43, Leng Han44, Guojun Gan45, Mengyue Yu46, Defeng Pan47, Zhenglu Shang48, Yanfang Zhao49, Zhizhong Liu50, Ye Yuan51, Cynthia Chen52, Gregg W Stone53, Yaling Han2, Shao-Liang Chen1,54.   

Abstract

AIM: The present study aimed to assess the benefits of two-stent techniques for patients with DEFINITION criteria-defined complex coronary bifurcation lesions. METHODS AND
RESULTS: In total, 653 patients with complex bifurcation lesions at 49 international centres were randomly assigned to undergo the systematic two-stent technique (two-stent group) or provisional stenting (provisional group). The primary endpoint was the composite of target lesion failure (TLF) at the 1-year follow-up, including cardiac death, target vessel myocardial infarction (TVMI), and clinically driven target lesion revascularization (TLR). The safety endpoint was definite or probable stent thrombosis. At the 1-year follow-up, TLF occurred in 37 (11.4%) and 20 (6.1%) patients in the provisional and two-stent groups, respectively [77.8%: double-kissing crush; hazard ratio (HR) 0.52, 95% confidence interval (CI) 0.30-0.90; P = 0.019], largely driven by increased TVMI (7.1%, HR 0.43, 95% CI 0.20-0.90; P = 0.025) and clinically driven TLR (5.5%, HR 0.43, 95% CI 0.19-1.00; P = 0.049) in the provisional group. At the 1 year after indexed procedures, the incidence of cardiac death was 2.5% in the provisional group, non-significant to 2.1% in the two-stent group (HR 0.86, 95% CI 0.31-2.37; P = 0.772).
CONCLUSION: For DEFINITION criteria-defined complex coronary bifurcation lesions, the systematic two-stent approach was associated with a significant improvement in clinical outcomes compared with the provisional stenting approach. Further study is urgently warranted to identify the mechanisms contributing to the increased rate of TVMI after provisional stenting. STUDY REGISTRATION: http://www.clinicaltrials.com; Identifier: NCT02284750. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Coronary bifurcation lesions; Provisional stenting; Stent thrombosis; Target lesion failure; Two-stent strategy

Mesh:

Year:  2020        PMID: 32588060     DOI: 10.1093/eurheartj/ehaa543

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  19 in total

Review 1.  Towards a common pathway for the treatment of left main disease: contemporary evidence and future directions: Left main disease treatment.

Authors:  Dejan Milasinovic; Goran Stankovic
Journal:  AsiaIntervention       Date:  2021-12

2.  Stenting left main disease: all roads lead to Rome: Stenting left main disease.

Authors:  Shao-Liang Chen
Journal:  AsiaIntervention       Date:  2021-12

3.  Practice Patterns in the Interventional Treatment of Coronary Bifurcation Lesions: A Global Survey.

Authors:  Ilias Nikolakopoulos; Evangelia Vemmou; Judit Karacsonyi; Lorenzo Azzalini; Brian A Bergmark; Yiannis S Chatzizisis; Allison B Hall; Jason Wollmuth; Kevin Croce; Hani Jneid; Bavana V Rangan; M Nicholas Burke; Emmanouil S Brilakis
Journal:  J Invasive Cardiol       Date:  2022-01       Impact factor: 2.022

4.  A Frequentist Opting for the Road Less Traveled.

Authors:  Mirvat Alasnag; Mamas A Mamas
Journal:  J Am Heart Assoc       Date:  2022-06-20       Impact factor: 6.106

Review 5.  Systematic Review and Network Meta-Analysis Comparing Bifurcation Techniques for Percutaneous Coronary Intervention.

Authors:  Dae Yong Park; Seokyung An; Neeraj Jolly; Steve Attanasio; Neha Yadav; Sunil Rao; Aviral Vij
Journal:  J Am Heart Assoc       Date:  2022-06-20       Impact factor: 6.106

Review 6.  [Bifurcation lesions : Are new strategies and devices needed?]

Authors:  Luise Gaede
Journal:  Herz       Date:  2022-10-21       Impact factor: 1.740

7.  Diagnostic value of clinical risk scores for predicting normal stress myocardial perfusion imaging in subjects without coronary artery calcium.

Authors:  Rosario Megna; Carmela Nappi; Valeria Gaudieri; Teresa Mannarino; Roberta Assante; Emilia Zampella; Roberta Green; Valeria Cantoni; Adriana D'Antonio; Parthiban Arumugam; Wanda Acampa; Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2020-06-29       Impact factor: 5.952

8.  Randomized non-inferiority TrIal comParing reverse T And Protrusion versus double-kissing and crush Stenting for the treatment of complex left main bifurcation lesions.

Authors:  Maximilian Olschewski; Helen Ullrich; Maike Knorr; Giulio Makmur; Majid Ahoopai; Thomas Münzel; Tommaso Gori
Journal:  Clin Res Cardiol       Date:  2021-11-24       Impact factor: 6.138

Review 9.  Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials.

Authors:  Aileen Kearney; Katie Linden; Patrick Savage; Ian B A Menown
Journal:  Adv Ther       Date:  2021-04-12       Impact factor: 3.845

10.  Percutaneous coronary intervention for bifurcation coronary lesions: the 15th consensus document from the European Bifurcation Club.

Authors:  Francesco Burzotta; Jens Flensted Lassen; Thierry Lefèvre; Adrian P Banning; Yiannis S Chatzizisis; Thomas William Johnson; Miroslaw Ferenc; Sudhir Rathore; Remo Albiero; Manuel Pan; Olivier Darremont; David Hildick-Smith; Alaide Chieffo; Marco Zimarino; Yves Louvard; Goran Stankovic
Journal:  EuroIntervention       Date:  2021-03-19       Impact factor: 6.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.